Periodontitis and rheumatoid arthritis-Global efforts to untangle two complex diseases.

Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Clin Periodontol. 2013;40:S8-S19. doi:10.1111/jcpe.12064

Bartold PM, Lopez-Oliva I. Periodontitis and rheumatoid arthritis: an update 2012-2017. Periodontol 2000. 2020;83(1):189-212. doi:10.1111/prd.12300

Hussain SB, Botelho J, Machado V, et al. Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(3):414-422. doi:10.1016/j.semarthrit.2020.01.009

Ribeiro J, Leao A, Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. J Clin Periodontol. 2005;32(4):412-416. doi:10.1111/j.1600-051X.2005.00689.x

Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol. 2007;13(3):134-137. doi:10.1097/RHU.0b013e3180690616

Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009;80(4):535-540. doi:10.1902/jop.2009.080447

Pinho MD, Oliveira RD, Novaes AB Jr, Voltarelli JC. Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment. Braz Dent J. 2009;20(5):355-364. doi:10.1590/S0103-64402009000500001

Okada M, Kobayashi T, Ito S, et al. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and Citrulline in patients with rheumatoid arthritis and periodontitis. J Periodontol. 2013;84(12):e74-e84. doi:10.1902/jop.2013.130079

Monsarrat P, Fernandez de Grado G, Constantin A, et al. The effect of periodontal treatment on patients with rheumatoid arthritis: the ESPERA randomised controlled trial. Joint Bone Spine. 2019;86(5):600-609. doi:10.1016/j.jbspin.2019.02.006

Kaushal S, Singh AK, Lal N, das SK, Mahdi AA. Effect of periodontal therapy on disease activity in patients of rheumatoid arthritis with chronic periodontitis. J Oral Biol Craniofac Res. 2019;9(2):128-132. doi:10.1016/j.jobcr.2019.02.002

Mariette X, Perrodeau E, Verner C, et al. Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort. Rheumatology. 2020;59(5):988-996. doi:10.1093/rheumatology/kez368

Nguyen VB, Nguyen TT, Huynh NC, Nguyen KD, Le TA, Hoang HT. Effects of non-surgical periodontal treatment in rheumatoid arthritis patients: a randomized clinical trial. Dent Med Probl. 2021;58(1):97-105. doi:10.17219/dmp/131266

Balci Yuce H, Gokturk O, Aydemir Turkal H, Inanir A, Benli I, Demir O. Assessment of local and systemic 25-hydroxy-vitamin D, RANKL, OPG, and TNF levels in patients with rheumatoid arthritis and periodontitis. J Oral Sci. 2017;59(3):397-404. doi:10.2334/josnusd.16-0677

Kurgan S, Önder C, Balcı N, et al. Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy. J Periodontal Res. 2017;52(3):574-581. doi:10.1111/jre.12425

Zhao X, Liu Z, Shu D, et al. Association of periodontitis with rheumatoid arthritis and the effect of non-surgical periodontal treatment on disease activity in patients with rheumatoid arthritis. Med Sci Monit. 2018;24:5802-5810. doi:10.12659/MSM.909117

Cosgarea R, Tristiu R, Dumitru RB, et al. Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis. Clin Oral Investig. 2019;23(1):141-151. doi:10.1007/s00784-018-2420-3

Kaneko C, Kobayashi T, Ito S, et al. Association among periodontitis severity, anti-agalactosyl immunoglobulin G titer, and the disease activity of rheumatoid arthritis. J Periodontal Res. 2021;56(4):702-709. doi:10.1111/jre.12867

Bialowas K, Radwan-Oczko M, Duś-Ilnicka I, Korman L, Świerkot J. Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis. Rheumatol Int. 2020;40(3):455-463. doi:10.1007/s00296-019-04460-z

Moller B, Kollert F, Sculean A, Villiger PM. Infectious triggers in periodontitis and the gut in rheumatoid arthritis (RA): a complex story about association and causality. Front Immunol. 2020;11:1108. doi:10.3389/fimmu.2020.01108

Moura MF, Cota LOM, Silva TA, et al. Clinical and microbiological effects of non-surgical periodontal treatment in individuals with rheumatoid arthritis: a controlled clinical trial. Odontology. 2021;109(2):484-493. doi:10.1007/s10266-020-00566-0

Elsadek MF, Farahat MF. Impact of photodynamic therapy as an adjunct to non-surgical periodontal treatment on clinical and biochemical parameters among patients having mild rheumatoid arthritis with periodontitis. Photodiagnosis Photodyn Ther. 2021;37:102698. doi:10.1016/j.pdpdt.2021.102698

Silva DS, Costa F, Baptista IP, et al. Evidence-based research on effectiveness of periodontal treatment in rheumatoid arthritis patients: a systematic review and meta-analysis. Arthritis Care Res. 2021;74:1723-1735. doi:10.1002/acr.24622

de Pablo P, Serban S, Lopez-Oliva I, et al. Outcomes of periodontal therapy in rheumatoid arthritis: the <scp>OPERA</scp> feasibility randomized trial. J Clin Periodontol. 2023;50(3):295-306. doi:10.1111/jcpe.13756

Grayling MJ, Bigirumurame T, Cherlin S, Ouma L, Zheng H, Wason JMS. Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. BMC Rheumatology. 2021;5(1):21. doi:10.1186/s41927-021-00192-5

Huang Y, Zhang Z, Zheng Y, et al. Effects of non-surgical periodontal therapy on periodontal clinical data in periodontitis patients with rheumatoid arthritis: a meta-analysis. BMC Oral Health. 2021;21(1):340. doi:10.1186/s12903-021-01695-w

Kobayashi T, Ito S, Murasawa A, Ishikawa H, Tabeta K. Periodontitis severity affects the clinical response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a 1-year follow-up study. Mod Rheumatol. 2021;33:81-87. doi:10.1093/mr/roab121

Jung G-U, Han JY, Hwang KG, Park CJ, Stathopoulou PG, Fiorellini JP. Effects of conventional synthetic disease-modifying antirheumatic drugs on response to periodontal treatment in patients with rheumatoid arthritis. Biomed Res Int. 2018;2018:1465402. doi:10.1155/2018/1465402

Ayravainen L, Heikkinen AM, Kuuliala A, et al. Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease. Oral Dis. 2018;24(8):1562-1571. doi:10.1111/odi.12930

Ziebolz D, Rupprecht A, Schmickler J, et al. Association of different immunosuppressive medications with periodontal condition in patients with rheumatoid arthritis: results from a cross-sectional study. J Periodontol. 2018;89(11):1310-1317. doi:10.1002/JPER.17-0616

Heredia-P AM, Lafaurie GI, Bautista-Molano W, et al. Predictive factors related to the progression of periodontal disease in patients with early rheumatoid arthritis: a cohort study. BMC Oral Health. 2019;19(1):240. doi:10.1186/s12903-019-0939-6

Ancuta C, Pomirleanu C, Mihailov C, et al. Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis. Joint Bone Spine. 2020;87(3):235-239. doi:10.1016/j.jbspin.2019.12.003

de Smit MJ, Westra J, Posthumus MD, et al. Effect of anti-rheumatic treatment on the periodontal condition of rheumatoid arthritis patients. Int J Environ Res Public Health. 2021;18(5):2529-2537. doi:10.3390/ijerph18052529

Pettas E, Savva V, Theofilou VI, Georgaki M, Nikitakis NG. Oral Candida infection in psoriatic patients treated with IL17A inhibitors: report of 3 cases and a comprehensive review of the literature. Diagnostics. 2021;12(1):3. doi:10.3390/diagnostics12010003

Brianti P, Paolino G, Mercuri SR. Successful use and safety of secukinumab in psoriatic patients with periodontitis: a valid therapeutic option. Dermatol Ther. 2020;33(3):e13350. doi:10.1111/dth.13350

Fujita Y, Sugai T, Maya Y, Inamura E, Hirano Y, Shimizu S. Secukinumab-induced oral lichen planus in a psoriatic arthritis patient ameliorated after a switch to risankizumab. J Dermatol. 2023;50:824-827. doi:10.1111/1346-8138.16719

Liu L, Yan YD, Shi FH, Lin HW, Gu ZC, Li J. Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: a systematic review and meta-analysis. Front Immunol. 2022;13:1-10. doi:10.3389/fimmu.2022.977265

European Medicines Agency. EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders. 2022. https://www.ema.europa.eu/en/news/ema-recommends-measures-minimise-risk-serious-side-effects-janus-kinase-inhibitors-chronic

Ytterberg SR, Bhatt DL, Mikuls TR, et al. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med. 2022;386(4):316-326. doi:10.1056/NEJMoa2109927

Brewer RC, Lanz TV, Hale CR, et al. Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis. Sci Transl Med. 2023;15(684):eabq8476. doi:10.1126/scitranslmed.abq8476

Chriswell ME, Lefferts AR, Clay MR, et al. Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum. Sci Transl Med. 2022;14(668):eabn5166. doi:10.1126/scitranslmed.abn5166

Hong M, Li Z, Liu H, et al. Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles. Cell Host Microbe. 2023;31(5):798-810.e7. doi:10.1016/j.chom.2023.03.018

Li X, Wang H, Yu X, et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell. 2022;185(10):1709-1727.e18. doi:10.1016/j.cell.2022.03.043

Che Rahim MJ, Wan Mohamad WM, Saddki N, et al. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis. Malays J Pathol. 2019;41(3):267-272. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med16&NEWS=N&AN=31901911

Loutan L, Alpizar-Rodriguez D, Courvoisier DS, Finckh A, Mombelli A, Giannopoulou C. Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis. J Clin Periodontol. 2019;46(7):690-698. doi:10.1111/jcpe.13117

Chila-Moreno L, Rodríguez LS, Bautista-Molano W, Bello-Gualtero JM, Ramos-Casallas A, Romero-Sánchez C. Anti-carbamylated protein and peptide antibodies as potential inflammatory joint biomarkers in the relatives of rheumatoid arthritis patients. Int J Rheum Dis. 2020;23(12):1698-1706. doi:10.1111/1756-185X.13977

Gonzalez-Febles J, Rodríguez-Lozano B, Sánchez-Piedra C, et al. Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: a cross-sectional study. Arthritis Res Ther. 2020;22(1):27. doi:10.1186/s13075-020-2121-6

Rahajoe PS, de Smit M, Schuurmans G, et al. Increased IgA anti-citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients. J Clin Periodontol. 2020;47(5):552-560. doi:10.1111/jcpe.13277

Svard A, Renvert S, Sanmartin Berglund J, et al. Antibodies to citrullinated peptides in serum and saliva in patients with rheumatoid arthritis and their association to periodontitis. Clin Exp Rheumatol. 2020;38(4):699-704. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med17&NEWS=N&AN=31820729

Manoil D, Courvoisier DS, Gilbert B, et al. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. Rheumatology (Oxford). 2021;60(10):4755-4764. doi:10.1093/rheumatology/keab097

Manoil D, Bostanci N, Mumcu, G, et al. Novel and known periodontal pathogens residing in gingival crevicular fluid are associated with rheumatoid arthritis. J Periodontol. 2021b;92:359-370.

Lew PH, Rahman MT, Safii SH, et al. Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study. BMC Oral Health. 2021;21(1):360. doi:10.1186/s12903-021-01712-y

Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012;64(10):3083-3094. doi:10.1002/art.34539

Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895-905. doi:10.1038/nm.3914

Lopez-Oliva I, Paropkari AD, Saraswat S, et al. Dysbiotic subgingival microbial communities in Periodontally healthy patients with rheumatoid arthritis. Arthritis Rheumatol (Hoboken, N.J.). 2018;70(7):1008-1013. doi:10.1002/art.40485

Beyer K, Zaura E, Brandt BW, et al. Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health. PloS One. 2018;13(9):e0202278. doi:10.1371/journal.pone.0202278

Chen B, Zhao Y, Li S, et al. Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening. Sci Rep. 2018;8(1):17126. doi:10.1038/s41598-018-35473-6

Correa JD, Fernandes GR, Calderaro DC, et al. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Sci Rep. 2019;9(1):8379. doi:10.1038/s41598-019-44674-6

Eriksson K, Fei G, Lundmark A, et al. Periodontal health and Oral microbiota in patients with rheumatoid arthritis. J Clin Med. 2019;8(5):630. doi:10.3390/jcm8050630

Esberg A, Johansson L, Johansson I, Dahlqvist SR. Oral microbiota identifies patients in early onset rheumatoid arthritis. Microorganisms. 2021;9(8):1657. doi:10.3390/microorganisms9081657

Janssen KMJ, de Smit MJ, Withaar C, et al. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients. J Clin Periodontol. 2017;44(6):577-584. doi:10.1111/jcpe.12727

Engstrom M, Eriksson K, Lee L, et al. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis. J Transl Med. 2018;16(1):214. doi:10.1186/s12967-018-1588-2

Zhao R, Gu C, Zhang Q, et al. Periodontal disease in Chinese patients with rheumatoid arthritis: a case-control study. Oral Dis. 2019;25(8):2003-2009. doi:10.1111/odi.13176

Maldonado A, Pirracchio L, Imber JC, et al. Citrullination in periodontium is associated with Porphyromonas gingivalis. Arch Oral Biol. 2020;114:104695. doi:10.1016/j.archoralbio.2020.104695

Panezai J, Ali A, Ghaffar A, et al. Upregulation of circulating inflammatory biomarkers under the influence of periodontal disease in rheumatoid arthritis patients. Cytokine. 2020;131:155117. doi:10.1016/j.cyto.2020.155117

Karapetsa D, Consensi A, Castagnoli G, et al. Periodontitis in Italian patients with established rheumatoid arthritis: a cross-sectional study. Oral Dis. 2021;28:1715-1722. doi:10.1111/odi.13842

Lee YH, Baharuddin NA, Chan SW, et al. Localisation of citrullinated and carbamylated proteins in inflamed gingival tissues from rheumatoid arthritis patients. Clin Oral Investig. 2021a;25(3):1441-1450. doi:10.1007/s00784-020-03452-9

Gamel EB, Hashim NT, Satti A, Gismalla BG. Salivary TNFalpha levels in groups of subjects with rheumatoid arthritis and chronic periodontitis. BMC Res Notes. 2017;10(1):34. doi:10.1186/s13104-016-2341-7

Kirchner A, Jäger J, Krohn-Grimberghe B, et al. Active matrix metalloproteinase-8 and periodontal bacteria depending on periodontal status in patients with rheumatoid arthritis. J Periodontal Res. 2017;52(4):745-754. doi:10.1111/jre.12443

Silvestre-Rangil J, Bagan L, Silvestre F, Martinez-Herrera M, Bagan J. Periodontal, salivary and IL-6 status in rheumatoid arthritis patients. A cross-sectional study. Med Oral Patol Oral Cir Bucal. 2017;22(5):e595-e600. doi:10.4317/medoral.21937

Ayravainen L, Heikkinen AM, Kuuliala A, et al. Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status. Ann Med. 2018;50(4):333-344. doi:10.1080/07853890.2018.1468922

Kaneko C, Kobayashi T, Ito S, et al. Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: a pilot case-control study. PloS One. 2018;13(2):e0192365. doi:10.1371/journal.pone.0192365

Panezai J, Ghaffar A, Altamash M, Engström PE, Larsson A. Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis. PloS One. 2018;13(6):e0197235. doi:10.1371/journal.pone.0197235

Schmalz G, Davarpanah I, Jäger J, et al. MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - first results of a cross-sectional study. J Microbiol Immunol Infect. 2019;52(3):386-394. doi:10.1016/j.jmii.2017.07.016

Cheah CW, al-Maleki AR, Vadivelu J, et al. Salivary and serum cathelicidin LL-37 levels in subjects with rheumatoid arthritis and chronic periodontitis. Int J Rheum Dis. 2020;23(10):1344-1352. doi:10.1111/1756-185X.13919

Arvikar SL, Hasturk H, Strle K, et al. Periodontal inflammation and distinct inflammatory profiles in saliva and gingival crevicular fluid compared with serum and joints in rheumatoid arthritis patients. J Periodontol. 2021;92(10):1379-1391. doi:10.1002/JPER.20-0051

Inanc N, Mumcu G, Can M, et al. Elevated serum TREM-1 is associated with periodontitis and disease activity in rheumatoid arthritis. Sci Rep. 2021;11(1):2888. doi:10.1038/s41598-021-82335-9

Soderlin MK, Persson GR, Renvert S, Sanmartin Berglund J. Cytokines in gingival crevicular fluid in elderly rheumatoid arthritis patients in a population-based cross-sectional study: RANTES was associated with periodontitis. J Periodontal Res. 2021;56(5):907-916. doi:10.1111/jre.12887

Xiao F, Li C, Lin Y, et al. Increased risk of periodontitis occurrence in patients with rheumatoid arthritis and its association with the levels of IL-1beta and TNF-alpha in gingival crevicular fluid. Ann Palliat Med. 2021;10(8):9078-9087. doi:10.21037/apm-21-1782

Yilmaz D, Gönüllü E, Gürsoy M, Könönen E, Gürsoy UK. Salivary and serum concentrations of monocyte chemoattractant protein-1, macrophage inhibitory factor, and fractalkine in relation to rheumatoid arthritis and periodontitis. J Periodontol. 2021;92(9):1295-1305. doi:10.1002/JPER.20-0632

Nielen MMJ, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380-386. doi:10.1002/art.20018

Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum. 2009;60(6):1597-1603. doi:10.1002/art.24572

Catrina AI, Deane KD, Scher JU. Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology. 2014;55:keu469. doi:10.1093/rheumatology/keu469

Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6:727-730. doi:10.1038/nrrheum.2010.139

Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans -induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med. 2016;8(369). doi:10.1126/scitranslmed.aaj1921

Sherina N, de Vries C, Kharlamova N, et al. Antibodies to a citrullinated Porphyromonas gingivalis epitope are increased in early rheumatoid arthritis, and can Be produced by gingival tissue B cells: implications for a bacterial origin in RA etiology. Front Immunol. 2022;13:804822. doi:10.3389/fimmu.2022.804822

Johansson L, Sherina N, Kharlamova N, et al. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):201. doi:10.1186/s13075-016-1100-4

Lappin DF, Apatzidou D, Quirke AM, et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol. 2013;40(10):907-915. doi:10.1111/jcpe.12138

Terao C, Asai K, Hashimoto M, et al. Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population-the Nagahama study. J Autoimmun. 2015;59:85-90. doi:10.1016/j.jaut.2015.03.002

Yang N-Y, Wang CY, Chyuan IT, et al. Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy. J Formos Med Assoc. 2018;117(11):1003-1010. doi:10.1016/j.jfma.2017.11.006

Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62(9):2662-2672. doi:10.1002/art.27552

Malcolm J, Nyirenda MH, Brown JL, et al. C-terminal citrullinated peptide alters antigen-specific APC:T cell interactions leading to breach of immune tolerance. J Autoimmun. 2023;135:102994. doi:10.1016/j.jaut.2023.102994

Potempa J, Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(10):606-620. doi:10.1038/nrrheum.2017.132

Kharlamova N, Jiang X, Sherina N, et al. Antibodies to Porphyromonas gingivalis indicate interaction between Oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol. 2016;68(3):604-613. doi:10.1002/art.39491

Shimada A, Kobayashi T, Ito S, et al. Expression of anti- Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis. J Periodontal Res. 2016;51(1):103-111. doi:10.1111/jre.12288

Volkov M, Dekkers J, Loos BG, et al. Comment on "Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis". Sci Transl Med. 2018;10(433):eaan8349. doi:10.1126/scitranslmed.aan8349

Vaahtovuo J, Munukka E, Korkeamäki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35(8):1500-1505.

Schwenzer A, Quirke AM, Marzeda AM, et al. Association of Distinct Fine Specificities of anti-Citrullinated peptide antibodies with elevated immune responses to Prevotella intermedia in a subgroup of patients with rheumatoid arthritis and periodontitis. Arthritis Rheumatol (Hoboken, NJ). 2017;69(12):2303-2313. doi:10.1002/art.40227

Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol. 2015;13(10):605-619. doi:10.1038/nrmicro3525

Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol. 2007;34(11):931-937. doi:10.1111/j.1600-051X.2007.01133.x

Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44. doi:10.1038/nri3785

Correa MG, Sacchetti SB, Ribeiro FV, et al. Periodontitis increases rheumatic factor serum levels and citrullinated proteins in gingival tissues and alter cytokine balance in arthritic rats. PloS One. 2017;12(3):e0174442. doi:10.1371/journal.pone.0174442

de Aquino SG, Talbot J, Sônego F, et al. The aggravation of arthritis by periodontitis is dependent of IL-17 receptor A activation. J Clin Periodontol. 2017;44(9):881-891. doi:10.1111/jcpe.12743

Jung H, Jung SM, Rim YA, et al. Arthritic role of Porphyromonas gingivalis in collagen-induced arthritis mice. PloS One. 2017;12(11):e0188698. doi:10.1371/journal.pone.0188698

Kim D, Lee G, Huh YH, et al. NAMPT is an essential regulator of RA-mediated periodontal inflammation. J Dent Res. 2017;96(6):703-711. doi:10.1177/0022034517690389

Sato K, Takahashi N, Kato T, et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system. Sci Rep. 2017;7(1):6955. doi:10.1038/s41598-017-07196-7

Ebbers M, Lübcke PM, Volzke J, Kriebel K, Hieke C, Engelmann R. Interplay between P. gingivalis, F. nucleatum and A. actinomycetemcomitans in murine alveolar bone loss, arthritis onset and progression. Sci Rep. 2018;8(1):15129. doi:10.1038/s41598-018-33129-z

Jeong SH, Nam Y, Jung H, et al. Interrupting oral infection of Porphyromonas gingivalis with anti-FimA antibody attenuates bacterial dissemination to the arthritic joint and improves experimental arthritis. Exp Mol Med. 2018;50(3):e460. doi:10.1038/emm.2017.301

Munenaga S, Ouhara K, Hamamoto Y, et al. The involvement of C5a in the progression of experimental arthritis with Porphyromonas gingivalis infection in SKG mice. Arthritis Res Ther. 2018;20(1):247. doi:10.1186/s13075-018-1744-3

Pan W, Yin W, Yang L, et al. Inhibition of Ctsk alleviates periodontitis and comorbid rheumatoid arthritis via downregulation of the TLR9 signalling pathway. J Clin Periodontol. 2019;46(3):286-296. doi:10.1111/jcpe.13060

Courbon G, Rinaudo-Gaujous M, Blasco-Baque V, et al. Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat. Ann Rheum Dis. 2019;78(5):594-599. doi:10.1136/annrheumdis-2018-213697

Lubcke PM, Ebbers MN, Volzke J, et al. Periodontal treatment prevents arthritis in mice and methotrexate ameliorates periodontal bone loss. Sci Rep. 2019;9(1):8128. doi:10.1038/s41598-019-44512-9

Sakaguchi W, To M, Yamamoto Y, et al. Detection of anti-citrullinated protein antibody (ACPA) in saliva for rheumatoid arthritis using DBA mice infected with Porphyromonas gingivalis. Arch Oral Biol. 2019;108:104510. doi:10.1016/j.archoralbio.2019.104510

Scanu A, Giraudo C, Galuppini F, et al. Periodontal injection of lipopolysaccharide promotes arthritis development in mice. Inflammation. 2019;42(3):1117-1128. doi:10.1007/s10753-019-00975-6

Tsurumaki J, Paula LG, Aquino SG, Marcantonio E, Oliveira GJ, Marcantonio RA. Effect of avocado/soybean unsaponifiables on periodontal repair in rats with arthritis and induced periodontitis. J Appl Oral Sci. 2019;27:e20180602. doi:10.1590/1678-7757-2018-0602

Flak MB, Colas RA, Muñoz-Atienza E, Curtis MA, Dalli J, Pitzalis C. Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis. JCI Insight. 2019;4(13). doi:10.1172/jci.insight.125191

Buschhart A-L, Bolten L, Volzke J, et al. Periodontal pathogens alter the synovial proteome. Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice. PloS One. 2020;15(12):e0242868. doi:10.1371/journal.pone.0242868

Muñoz-Atienza E, Flak MB, Sirr J, et al. The P. gingivalis autocitrullinome is not a target for ACPA in early rheumatoid arthritis. J Dent Res. 2020;99(4):456-462. doi:10.1177/0022034519898144

Cardoso RS, Messora MR, Silva PHF, et al. Effects of Bifidobacterium animalis subsp. lactis HN019 on ligature-induced periodontitis in rats with experimental rheumatoid arthritis. Benef Microbes. 2020;11(1):33-46. doi:10.3920/BM2019.0038

Hamamoto Y, Ouhara K, Munenaga S, et al. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model. Arthritis Res Ther. 2020;22(1):249. doi:10.1186/s13075-020-02348-z

Wei W, Ren J, Yin W, et al. Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy. Cell Prolif. 2020;53(1):e12722. doi:10.1111/cpr.12722

Yue Y, Yin W, Yang Q, et al. Inhibition of cathepsin K alleviates autophagy-related inflammation in periodontitis-aggravating arthritis. Infect Immun. 2020;88(12):e00498-20. doi:10.1128/IAI.00498-20

Gusmao JNFM, Fonseca KM, Ferreira BS, et al. Electroacupuncture reduces inflammation but not bone loss on periodontitis in arthritic rats. Inflammation. 2021;44(1):116-128. doi:10.1007/s10753-020-01313-x

Karydis A, Sandal I, Luo J, et al. Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers. PloS One. 2021;16(4):e0250177. doi:10.1371/journal.pone.0250177

Zhou N, Zou F, Cheng X, et al. Porphyromonas gingivalis induces periodontitis, causes immune imbalance, and promotes rheumatoid arthritis. J Leukoc Biol. 2021;110(3):461-473. doi:10.1002/JLB.3MA0121-045R

de Arruda JAA, Corrêa JD, Singh Y, et al. Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota. Anaerobe. 2022;75:102577. doi:10.1016/j.anaerobe.2022.102577

Maresz KJ, Hellvard A, Sroka A, et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial Peptidylarginine deiminase (PAD). PLoS Pathog. 2013;9(9):e1003627. doi:10.1371/journal.ppat.1003627

Periodontitis and rheumatoid arthritis-Global efforts to untangle two complex diseases.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Informations de copyright

Références

Auteurs

Isabel Lopez-Oliva (I)

Jennifer Malcolm (J)

Shauna Culshaw (S)

Classifications MeSH